Canary Staked INJ ETF Wins Nasdaq Listing Approval
Canary Capital’s Staked INJ ETF secured Nasdaq listing approval under ticker INJC, advancing a product designed to combine Injective exposure with staking rewards.
This article may contain affiliate links. Commercial relationships are disclosed in the affiliate policy.
What happened
Canary Capital’s Staked INJ ETF secured Nasdaq listing approval under ticker INJC, advancing a product designed to combine Injective exposure with staking rewards. The fund plans to stake at least 90% of its INJ holdings under normal conditions, with BitGo as custodian and a 1.10% sponsor fee.
Reported details
- The fund expects to retain 70% of staking rewards before its separate 1.10% annual sponsor fee and other expenses.
Why this matters
Canary Staked INJ ETF carries pricing or financing terms rather than a structural change on its face. If it sets out a yield, a spread or a financing cost, the figure worth having is the net one: after issuer fees, redemption friction, and the credit behind the collateral. A headline number without those deductions is not a return, and this brief does not treat it as one.
Evidence boundary
On Canary Staked INJ ETF, the scope is limited to what the linked 2 reports state, and where they diverge both positions are recorded without either being picked in advance; the headline figure is what to check first.
What to verify
Read Canary Staked INJ ETF for any figure it actually states, net of issuer fees and redemption friction where those apply, alongside the credit standing of whatever collateral is named.
Sources and editorial check time
-
Crypto Economy RWA: https://crypto-economy.com/canary-staked-inj-etf-wins-nasdaq-listing/
-
The Defiant Live: https://thedefiant.io/news/tokens/canary-s-staked-inj-etf-begins-trading-on-nasdaq
-
Editorial source check time: 2026-11-05T16:50:11.688Z
This information is educational and is not financial, legal, or tax advice.